CRMD (STOCKS)
CorMedix Inc.
$7.210000
-0.030000 (-0.41%)
Prev close: $7.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joseph Todisco
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $578.65M
- Employees
- 82
- P/E (TTM)
- 3.57
- P/B (TTM)
- 1.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.18 | $0.83 | -0.6525 | -78.38% |
|
Sep 2025 (Q3)
|
$1.26 | $0.66 | +0.6019 | +91.46% |
|
Jun 2025 (Q2)
|
$0.28 | $0.18 | +0.1037 | +58.82% |
|
Mar 2025 (Q1)
|
$0.30 | $0.27 | +0.0348 | +13.12% |
Financial Statements
| Revenues | $311.71M |
| Benefits Costs and Expenses | $161.69M |
| Cost Of Revenue | $22.09M |
| Costs And Expenses | $161.69M |
| Gross Profit | $275.75M |
| Nonoperating Income/Loss | -$125.00K |
| Operating Expenses | $125.61M |
| Research and Development | $19.33M |
| Other Operating Expenses | $106.27M |
| Operating Income/Loss | $150.14M |
| Income/Loss From Continuing Operations After Tax | $1.70M |
| Income/Loss From Continuing Operations Before Tax | $150.02M |
| Income Tax Expense/Benefit | -$13.04M |
| Income Tax Expense/Benefit, Current | $12.76M |
| Income Tax Expense/Benefit, Deferred | -$25.80M |
| Net Income/Loss | $163.06M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $163.06M |
| Net Income/Loss Available To Common Stockholders, Basic | $163.06M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.25 |
| Diluted Earnings Per Share | $2.04 |
| Basic Average Shares | 72,034 |
| Diluted Average Shares | 80,308 |
| Assets | $826.14M |
| Current Assets | $367.05M |
| Inventory | $29.72M |
| Other Current Assets | $337.34M |
| Noncurrent Assets | $459.09M |
| Fixed Assets | $5.96M |
| Intangible Assets | $379.07M |
| Other Non-current Assets | $74.06M |
| Liabilities | $420.84M |
| Current Liabilities | $174.27M |
| Accounts Payable | $7.88M |
| Other Current Liabilities | $166.39M |
| Noncurrent Liabilities | $246.57M |
| Equity | $405.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $405.31M |
| Liabilities And Equity | $826.14M |
| Net Cash Flow From Operating Activities | $175.05M |
| Net Cash Flow From Operating Activities, Continuing | $175.05M |
| Net Cash Flow From Investing Activities | -$308.43M |
| Net Cash Flow From Investing Activities, Continuing | -$308.43M |
| Net Cash Flow From Financing Activities | $238.45M |
| Net Cash Flow From Financing Activities, Continuing | $238.45M |
| Net Cash Flow | $105.07M |
| Net Cash Flow, Continuing | $105.07M |
| Comprehensive Income/Loss | -$88.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$88.00K |
| Other Comprehensive Income/Loss | -$88.00K |